Literature DB >> 8937515

The vascular endothelial barrier--selective retention of lipoproteins.

B G Nordestgaard1.   

Abstract

New experimental evidence in vivo suggests that, upon entrance into the arterial intima, IDL and VLDL become trapped at least to the same extent as LDL, and that lipoprotein(a) in normal arteries becomes trapped to the same extent as LDL. In the injured vessel, however, lipoprotein(a) seems to be trapped more than LDL. Further, new evidence also suggests that mildly oxidized LDL may circulate in plasma for a period long enough to enter, accumulate, and be degraded in the arterial intima in preference to normal LDL.

Mesh:

Substances:

Year:  1996        PMID: 8937515     DOI: 10.1097/00041433-199610000-00002

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  10 in total

1.  Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease.

Authors:  Edward K Duran; Aaron W Aday; Nancy R Cook; Julie E Buring; Paul M Ridker; Aruna D Pradhan
Journal:  J Am Coll Cardiol       Date:  2020-05-05       Impact factor: 24.094

Review 2.  Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.

Authors:  Børge G Nordestgaard; Anne Langsted
Journal:  J Lipid Res       Date:  2016-09-27       Impact factor: 5.922

3.  Changes in Impaired Fasting Glucose and Borderline High Low-Density Lipoprotein-Cholesterol Status Alter the Risk of Cardiovascular Disease: A 9-Year Prospective Cohort Study.

Authors:  Xianxuan Wang; Yan-Feng Zhou; Zegui Huang; Xinran Yu; Zekai Chen; Zefeng Cai; Yulong Lan; Werijian Li; Zhiwei Cai; Wei Fang; Guanzhi Chen; Weiqiang Wu; Shouling Wu; Youren Chen
Journal:  Front Cardiovasc Med       Date:  2022-06-21

Review 4.  From embryonic development to human diseases: The functional role of caveolae/caveolin.

Authors:  Jihee Sohn; Rachel M Brick; Rocky S Tuan
Journal:  Birth Defects Res C Embryo Today       Date:  2016-03-17

5.  Catalytically inactive lipoprotein lipase expression in muscle of transgenic mice increases very low density lipoprotein uptake: direct evidence that lipoprotein lipase bridging occurs in vivo.

Authors:  M Merkel; Y Kako; H Radner; I S Cho; R Ramasamy; J D Brunzell; I J Goldberg; J L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

Review 6.  Novel Functions of Endothelial Scavenger Receptor Class B Type I.

Authors:  Liming Yu; Yao Dai; Chieko Mineo
Journal:  Curr Atheroscler Rep       Date:  2021-01-09       Impact factor: 5.967

7.  Amount of hepatic fat predicts cardiovascular risk independent of insulin resistance among Hispanic-American adolescents.

Authors:  Ran Jin; Ngoc-Anh Le; Rebecca Cleeton; Xiaoyan Sun; Jessica Cruz Muños; James Otvos; Miriam B Vos
Journal:  Lipids Health Dis       Date:  2015-05-01       Impact factor: 3.876

8.  Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.

Authors:  Jan Borén; M John Chapman; Ronald M Krauss; Chris J Packard; Jacob F Bentzon; Christoph J Binder; Mat J Daemen; Linda L Demer; Robert A Hegele; Stephen J Nicholls; Børge G Nordestgaard; Gerald F Watts; Eric Bruckert; Sergio Fazio; Brian A Ference; Ian Graham; Jay D Horton; Ulf Landmesser; Ulrich Laufs; Luis Masana; Gerard Pasterkamp; Frederick J Raal; Kausik K Ray; Heribert Schunkert; Marja-Riitta Taskinen; Bart van de Sluis; Olov Wiklund; Lale Tokgozoglu; Alberico L Catapano; Henry N Ginsberg
Journal:  Eur Heart J       Date:  2020-06-21       Impact factor: 29.983

Review 9.  Endothelial Transcytosis of Lipoproteins in Atherosclerosis.

Authors:  Xinbo Zhang; William C Sessa; Carlos Fernández-Hernando
Journal:  Front Cardiovasc Med       Date:  2018-09-25

10.  Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect.

Authors:  Gerd Hörl; Harald Froehlich; Ulrika Ferstl; Gerhard Ledinski; Josepha Binder; Gerhard Cvirn; Tatjana Stojakovic; Michael Trauner; Christoph Koidl; Erwin Tafeit; Karin Amrein; Hubert Scharnagl; Günther Jürgens; Seth Hallström
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.